GB818248A - Improvements in and relating to the production of adrenocorticotrophin preparation of enhanced stability - Google Patents
Improvements in and relating to the production of adrenocorticotrophin preparation of enhanced stabilityInfo
- Publication number
- GB818248A GB818248A GB35176/56A GB3517656A GB818248A GB 818248 A GB818248 A GB 818248A GB 35176/56 A GB35176/56 A GB 35176/56A GB 3517656 A GB3517656 A GB 3517656A GB 818248 A GB818248 A GB 818248A
- Authority
- GB
- United Kingdom
- Prior art keywords
- adrenocorticotrophin
- preparation
- enhanced stability
- relating
- production
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- A61K38/35—Corticotropin [ACTH]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
An adrenocorticotrophin preparation for parenteral administration of enhanced stability comprises an aqueous solution having a pH from 5.5-7.5 of ACTH in combination with gelatine and an organic reducing agent containing at least one sulphydryl group such as, preferably cysteine, or beta-mercapto-ethanol or thioglycollic acid. The pH may be obtained by the addition of agents such as sodium hydroxide or trisodium phosphate. A specially desirable pH is from 6.5 to 7.0. The concentration of the organic reducing agent may be from 0.025 to 0.2 per cent (weight/volume) with a concentration of 0.1 per cent specially desirable. Specification 725,421 is referred to.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US818248XA | 1955-11-17 | 1955-11-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB818248A true GB818248A (en) | 1959-08-12 |
Family
ID=22166632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB35176/56A Expired GB818248A (en) | 1955-11-17 | 1956-11-16 | Improvements in and relating to the production of adrenocorticotrophin preparation of enhanced stability |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB818248A (en) |
-
1956
- 1956-11-16 GB GB35176/56A patent/GB818248A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1417003A (en) | Stabilisation of fibrinogen | |
GB824908A (en) | Improvements in or relating to triazine derivatives | |
GB818248A (en) | Improvements in and relating to the production of adrenocorticotrophin preparation of enhanced stability | |
GB739800A (en) | Aqueous pharmaceutical solutions of reserpine for parenteral administration | |
ES326448A1 (en) | Procedure for obtaining a therapeutic composition of mucolitic action. (Machine-translation by Google Translate, not legally binding) | |
ES391536A1 (en) | Procedure for obtaining antibacterial compositions. (Machine-translation by Google Translate, not legally binding) | |
GB816592A (en) | A method for the preparation of stable magnesium solutions of high concentration | |
GB812575A (en) | Improvements in or relating to sweetening compositions and method for making same | |
GB997823A (en) | Improved pharmaceutical solutions of sodium antimonylgluconate and the production thereof | |
GB700774A (en) | Stabilised aqueous solutions of sodium p-aminosalicylate and production of the same | |
GR75654B (en) | ||
GB942876A (en) | Improvements in or relating to piperidylidene-thiaxanthene | |
GB713720A (en) | Improvements in or relating to the preparation of stabilized liquid catalase | |
ES290193A1 (en) | Heparin derivatives and methods for preparing same | |
GB806908A (en) | Improvements in or relating to new aqueous solutions of monosemicarbazone of adrenochrome | |
ES294928A1 (en) | A procedure to prepare a liquid and stable composition of tetracycline (Machine-translation by Google Translate, not legally binding) | |
ES424362A1 (en) | Method of stabilizing a topical ophthalmic formulation | |
GB773557A (en) | Improvements in or relating to a process for the preparation of therapeutic compositions having prolonged activity and compositions formed thereby | |
GB1217135A (en) | Daunomycin derivatives | |
GB954264A (en) | New hydrazones and process for preparing same | |
GB1001704A (en) | Process for the production of water soluble derivatives of ªÐ-amino-salicylic acid | |
GB480503A (en) | Process for the manufacture of stable solutions of ascorbic acid salts of histidine | |
GB968412A (en) | Improvements in or relating to theophylline derivatives | |
GB941295A (en) | Improvements in or relating to dipilatories | |
ES458413A1 (en) | Pharmaceutical composition |